PACAP and VIP stimulate ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-β

Journal of Neuroendocrinology

Volumn 8, Issue 5, 1996, Pages 367-374

  Hezareh, Marjan ^a   Schlegel, Werner ^a   Rawlings, Stephen R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Pituitary adenylate cyclase activating polypeptide; Vasoactive intestinal polypeptides

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; GONADOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; GONADOTROPIN SECRETING CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENYLATE CYCLASE TOXIN; ANIMALS; CALCIUM; CELLS, CULTURED; CULTURE MEDIA; ESTRENES; FLUORESCENT DYES; GTP-BINDING PROTEINS; ISOENZYMES; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PERIODICITY; PERTUSSIS TOXIN; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY GLAND, ANTERIOR; PYRROLIDINONES; RATS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; VASOACTIVE INTESTINAL PEPTIDE; VIRULENCE FACTORS, BORDETELLA;

EID: 0029881071     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04645.x     Document Type: Article

References (43)

1. Miyata A, Arimura A, Dahl DH, et al. Isolation of a novel 38 residue hypothalamic peptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567-574.
2. Miyata A, Dahl DH, Jiang L, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 amino acids (PACAP38). Biochem Biophys Res Commun 1990; 170: 643-648.
3. Arimura A. Pituitary adenylate cyclase-activating polypeptide (PACAP): discovery and current status of research. Reg Peptides 1992; 37: 287-303.
4. Christophe J, Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1993; 1154: 183-199.
5. Rawlings SR, Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/VIP receptors: actions on the anterior pituitary gland. Endocr rev 1996; (in press).
6. Rostène WH. Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Prog Neurobiol. 1984; 22: 103-129
7. Köves K, Arimura A, Gorcs TG, Somogyvari-Vigh A. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 1991; 54: 159-169.
8. Dow RC, Bennie J, Fink G. Pituitary adenylate cyclase-activating polypeptide (PACAP)-38 is released inro hypophysial portal blood in the normal male and female rat. J Endocrinol 1994; 142: R1-R4.
9. Gottschall PE, Tatsuno I, Miyata A, Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide. pituitary adenylate cyclase activating polypeptide. Endocrinology 1990; 127: 272-277.
10. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L. Differential expression of pituitary adenylate cyclase-activating polypeptide/ vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology 1995; 136: 2088-2098.
11. Culler MD, Paschall CS. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone. Endocrinology 1991; 129: 2260-2262.
12. Goth MI, Lyons, CE, Canny BJ, Thorner MO. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH (-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992; 130: 939-944.
13. Tatsuno I, Somogyvari-Vigh A, Mizuno K, et al. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology 1991; 129: 1797-1804.
14. Canny BJ, Rawlings SR, Leong DA. Pituitary adenylate cyclaseactivating polypeptide specifically increase cytosolic calcium concentration in rat gonadotropes and somatotropes. Endocrinalogy 1992; 130: 211-215.
15. Yada T, Vigh S, Arimura A. Pituitary adenylate cyclase activating polypeptide increases cytosolic-free calcium concentration in folliculo-stellate cells and somatotropes of rat pituitary. Peptides 1993; 14: 235-239.
16. 2+ in rat gonadotropes and somatotropes through different mechanisms. Endocrinology 1993; 132: 1447-1452.
17. i in rat gonadotrophs through an inositol trisphosphate-dependent mechanism. J Biol Chem 1994; 269: 5680-5686.
18. Pisegna JR, Wank SA. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Nutl Acacl Sci, USA 1993; 90: 6345-6349.
19. Spengler D, Waeber C, Pantaloni C, et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993; 365: 170-175.
20. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-819.
21. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 1993; 334: 3-8.
22. Inagaki N, Yoshida H, Mizuta M, et al. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci. USA 1994; 91: 2679-2683.
23. 1 receptors expreseed by stable transfectants couple to two distinct signaling pathways. Biochem Biophys Res Commun 1994; 203: 141-148.
24. Robberecht P, Gourlet P, de Neef P, et al. Structural requirements for the occupancy of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur J Biochem 1992; 207: 239-246.
25. 17]VIP. Am J Physiol. 1986; 250: G553-G557
26. Clapham DE, Neer EJ. New roles for G-protein βy-dimers in transmembrane signalling. Nature 1993; 365: 403-406.
27. 3 cells. FEBS Lett 1985; 189: 27-32.
28. 2- channels. J Clin Endocrinol Metab 1993; 76: 1265-1270.
29. Bleasdale JE, Thakur NR, Gremban RS, et al. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 1990; 255: 756-768.
30. Zheng L, Paik W-Y, Cesnjaj M, et al. Effects of the phospholipase-C inhibitor. U73122, on signaling and secretion in pituitary gonadotrophs. Endocrinology 1995; 136: 1079-1088.
31. 2+ oscillations in response to cholecystokinin and carbachol but not to J MV-180 in rat pancreatic acinar cells. J Biol Chem 1992; 267: 13830-13835.
32. Fatatis A, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT. Vasoactive intestinal polypeptide increases intracellular calcium in astroglia: synergism with α-adrenergic receptors. Proc Natl Acad Sci, USA 1994; 91: 2036-2040.
33. Robberecht P, Vertongen P, Velkeniers B. et al. Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas. J Clin Endocrinol Metab 1993; 77: 1235-1239.
34. Schomerus E, Poch A, Bunting R, Mason WT, McArdle CA. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotropederived αT3-1 cell line. Endocrinology 1994; 134: 315-323.
35. Segre GV, Goldring SR. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone belong to a newly discovered G-protein-linked receptor family. Trends Endo Metab 1993; 4: 309-314.
36. Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt WE Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain. Eur J Biochem 1991; 202: 951-958.
37. 11. Mol Endocrinol. 1992; 6: 1673-1681.
38. Buscail L, Cambillau C, Seva C, et al. Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary cyclase-activating polypeptide. Gatroenterology 1992; 103: 1002-1008.
39. s activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 1991; 67: 723-730.
40. Grierson P J, Meldolesi J. Calcium homeostasis in mouse fibroblast cells: affected by U-73122, a putative phospholipase Cβ blocker, via multiple mechanisms. Br J Pharmacol 1995; 115: 11-14.
41. q class of proteins. Nature 1991; 350: 516-518.
42. Demaurex N, Rawlings SR, Krause K-H, et al. Combination of microfluorimetric monitoring of cytosolic calcium and pH with patch clamp electrophysiological recordings in neutrophil granulocytes. Meth Enzymol. 1994; 238: 308-320.
43. 2+ indicators with greatly improved fluorecence properties. J Biol Chem 1985; 260: 3440-3450.